CapsoVision Inc. Submits FDA 510(k) Application, Shares Surge 8.4%
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Dec 30 2025
0mins
Source: Benzinga
- Stock Surge: CapsoVision, Inc. submitted its 510(k) application for the proprietary AI-assisted CapsoCam Plus module, resulting in an 8.4% increase in share price to $12.55 on Tuesday, indicating strong market confidence in its innovative technology.
- Successful Public Offering: AXT, Inc. priced its public offering at $12.25 per share, raising $87 million, which led to a 13.5% rise in its stock price to $16.56, reflecting investor recognition of its growth potential.
- Analyst Rating Upgrade: HC Wainwright & Co. maintained a Buy rating on Greenwich LifeSciences, Inc. and raised the price target from $39 to $50, contributing to a 13.6% increase in its stock price to $28.25, showcasing market optimism regarding its product prospects.
- Clinical Trial Update: SELLAS Life Sciences Group, Inc. provided an update on its Phase 3 REGAL trial for acute myeloid leukemia, resulting in a 12% increase in its stock price to $3.7537, indicating potential breakthroughs in treatment options.
Discover Tomorrow's Bullish Stocks Today
Receive free daily stock recommendations and professional analysis to optimize your portfolio's potential.
Sign up now to unlock expert insights and stay one step ahead of the market trends.
Analyst Views on AXTI
Wall Street analysts forecast AXTI stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for AXTI is 16.20 USD with a low forecast of 7.00 USD and a high forecast of 26.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
5 Analyst Rating
4 Buy
1 Hold
0 Sell
Strong Buy
Current: 17.200
Low
7.00
Averages
16.20
High
26.00
Current: 17.200
Low
7.00
Averages
16.20
High
26.00
About AXTI
AXT, Inc. is a material science company that develops and manufactures high-performance compound and single element semiconductor wafer substrates comprising indium phosphide (InP), gallium arsenide (GaAs) and germanium (Ge). Its wafer substrates are used when a typical silicon wafer substrate cannot meet the performance requirements of a semiconductor or optoelectronic device. It has two product lines: specialty material substrates and raw materials integral to these substrates. Its InP is a semiconductor wafer substrate used in broadband and fiber optic applications, 5G infrastructure and data center connectivity. Its semi-conducting GaAs substrates are used to create opto-electronic products, including high brightness light emitting diodes that are often used to backlight wireless handsets and LCD televisions and for automotive, signage, and lighting applications. Its Ge substrates are used in applications, such as solar cells for space and terrestrial photovoltaic applications.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Morgan Stanley Downgrades Domino's Pizza to Equal-Weight, Price Target Cut to $455
- Domino's Pizza Downgrade: Morgan Stanley analyst Brian Harbour downgraded Domino's Pizza (NASDAQ:DPZ) from Overweight to Equal-Weight, lowering the price target from $535 to $455, reflecting caution about future growth, as shares closed at $400.28 on Friday, indicating market concerns about the company's outlook.
- AXT Inc Rating Change: Needham analyst Charles Shi downgraded AXT Inc (NASDAQ:AXTI) from Buy to Hold, reflecting diminished confidence in its market performance, with shares closing at $22.09 on Friday, signaling investor caution regarding its future prospects.
- Philip Morris Rating Adjustment: Jefferies analyst Edward Mundy downgraded Philip Morris International Inc. (NYSE:PM) from Buy to Hold and cut the price target from $220 to $180, with shares closing at $173.62 on Friday, indicating market worries about its growth potential.
- ConocoPhillips Rating Maintained: JP Morgan analyst Arun Jayaram downgraded ConocoPhillips (NYSE:COP) from Overweight to Neutral while maintaining a price target of $98, with shares closing at $98.19 on Friday, reflecting cautious sentiment in the market regarding its future performance.
Continue Reading
Semiconductor Shares Rise 3.4%, Led by AXTI's 15.6% Gain
- Sector Performance: On Thursday, semiconductor shares collectively rose by approximately 3.4%, indicating strong market confidence in the sector, which may reflect investor optimism about future growth prospects.
- AXTI's Surge: AXTI's stock price increased by about 15.6%, making it the top performer of the day, suggesting its competitive strength in the market and investor confidence in its future earnings.
- Entegris Growth: Entegris saw its stock rise by approximately 11%, further solidifying its critical position in the semiconductor supply chain, potentially attracting more investor interest in its business developments.
- Market Trend Analysis: The robust performance of semiconductor stocks may signal a recovery in the tech sector, prompting investors to monitor the financial performance and market dynamics of related companies to seize potential investment opportunities.
Continue Reading